Spatial metabolomics for evaluating response to neoadjuvant therapy in non‐small cell lung cancer patients

BACKGROUND: The response to neoadjuvant chemotherapy (NAC) differs substantially among individual patients with non‐small cell lung cancer (NSCLC). Major pathological response (MPR) is a histomorphological read‐out used to assess treatment response and prognosis in patients NSCLC after NAC. Although...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Jian, Sun, Na, Zens, Philipp, Kunzke, Thomas, Buck, Achim, Prade, Verena M., Wang, Jun, Wang, Qian, Hu, Ronggui, Feuchtinger, Annette, Berezowska, Sabina, Walch, Axel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198346/
https://www.ncbi.nlm.nih.gov/pubmed/35593195
http://dx.doi.org/10.1002/cac2.12310

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198346/
https://www.ncbi.nlm.nih.gov/pubmed/35593195
http://dx.doi.org/10.1002/cac2.12310

Ejemplares similares